These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36180713)
1. Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds. De Gregorio D; Comai S Methods Mol Biol; 2022; 2550():453-461. PubMed ID: 36180713 [TBL] [Abstract][Full Text] [Related]
2. Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain. Posa L; De Gregorio D; Gobbi G; Comai S Curr Med Chem; 2018; 25(32):3866-3882. PubMed ID: 28183259 [TBL] [Abstract][Full Text] [Related]
5. Melatonin MT López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968 [TBL] [Abstract][Full Text] [Related]
6. Melatonin and their analogs as a potential use in the management of Neuropathic pain. Kuthati Y; Lin SH; Chen IJ; Wong CS J Formos Med Assoc; 2019 Aug; 118(8):1177-1186. PubMed ID: 30316678 [TBL] [Abstract][Full Text] [Related]
7. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states. Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151 [TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-κB/NLRP3 inflammasome signaling pathway. Wang YH; Tang YR; Gao X; Liu J; Zhang NN; Liang ZJ; Li Y; Pan LX Brain Res Bull; 2021 Apr; 169():156-166. PubMed ID: 33508403 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological mechanisms of alcohol analgesic-like properties in mouse models of acute and chronic pain. Neddenriep B; Bagdas D; Contreras KM; Ditre JW; Wolstenholme JT; Miles MF; Damaj MI Neuropharmacology; 2019 Dec; 160():107793. PubMed ID: 31562845 [TBL] [Abstract][Full Text] [Related]
10. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Taneja A; Della Pasqua O; Danhof M Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907 [TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. Wilhelmsen M; Amirian I; Reiter RJ; Rosenberg J; Gögenur I J Pineal Res; 2011 Oct; 51(3):270-7. PubMed ID: 21615490 [TBL] [Abstract][Full Text] [Related]
13. The analgesic action of larixyl acetate, a potent TRPC6 inhibitor, in rat neuropathic pain model induced by spared nerve injury. Wang J; Zhao M; Jia P; Liu FF; Chen K; Meng FY; Hong JH; Zhang T; Jin XH; Shi J J Neuroinflammation; 2020 Apr; 17(1):118. PubMed ID: 32299452 [TBL] [Abstract][Full Text] [Related]
14. Melatonin and its agonists in pain modulation and its clinical application. Srinivasan V; Zakaria R; Jeet Singh H; Acuna-Castroviejo D Arch Ital Biol; 2012 Dec; 150(4):274-89. PubMed ID: 23479460 [TBL] [Abstract][Full Text] [Related]
15. Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription. Lin TB; Hsieh MC; Lai CY; Cheng JK; Wang HH; Chau YP; Chen GD; Peng HY J Pineal Res; 2016 Apr; 60(3):263-76. PubMed ID: 26732138 [TBL] [Abstract][Full Text] [Related]
16. Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain. Liu YY; Yin D; Chen L; Qu WM; Chen CR; Laudon M; Cheng NN; Urade Y; Huang ZL Psychopharmacology (Berl); 2014 Oct; 231(20):3973-85. PubMed ID: 24700387 [TBL] [Abstract][Full Text] [Related]
17. A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance. Kashkin VA; Shekunova EV; Titov MI; Eliseev II; Gureev MA; Porozov YB; Makarova MN; Makarov VG Peptides; 2018 Jan; 99():61-69. PubMed ID: 29175519 [TBL] [Abstract][Full Text] [Related]
18. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain. Kiso T; Watabiki T; Sekizawa T Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705 [TBL] [Abstract][Full Text] [Related]
19. Potential use of melatonergic drugs in analgesia: mechanisms of action. Srinivasan V; Pandi-Perumal SR; Spence DW; Moscovitch A; Trakht I; Brown GM; Cardinali DP Brain Res Bull; 2010 Mar; 81(4-5):362-71. PubMed ID: 20005925 [TBL] [Abstract][Full Text] [Related]
20. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Hsieh GC; Pai M; Chandran P; Hooker BA; Zhu CZ; Salyers AK; Wensink EJ; Zhan C; Carroll WA; Dart MJ; Yao BB; Honore P; Meyer MD Br J Pharmacol; 2011 Jan; 162(2):428-40. PubMed ID: 20880025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]